Complete Filing Data
ADC Therapeutics SA reported Research And Development Expense of $104.01 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ADC Therapeutics SA did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$142.6M | -$157.8M | -$240.1M | -$157.1M | -$230.0M | -$246.3M | -$116.5M | -$123.1M |
| Revenue * | $81.4M | $70.8M | $69.1M | $74.9M | ||||
| Research And Development Expense | $104.0M | $109.6M | $127.1M | $186.5M | $158.0M | $142.0M | $107.5M | $118.3M |
| General And Administrative Expense | $36.6M | $41.9M | $48.4M | $74.4M | $71.5M | $55.1M | $14.2M | $8.8M |
| Share Of Profit Loss Of Joint Ventures Accounted For Using Equity Method | -$10.1M | -$6.7M | $24.4M | $0.00 | $0.00 | |||
| Sales And Marketing Expense | $69.1M | $64.8M | $22.1M | $0.00 | $0.00 | |||
| Profit Loss From Operating Activities | -$123.6M | -$261.7M | -$219.3M | -$119.4M | -$125.9M | |||
| Profit Loss Before Tax | -$154.7M | -$251.5M | -$246.0M | -$115.9M | -$122.9M | |||
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$539.0K | -$62.0K | $176.0K | $112.0K | -$79.0K | |||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$539.0K | -$62.0K | $176.0K | $112.0K | -$79.0K | |||
| Other Comprehensive Income | $3.2M | -$649.0K | -$129.0K | -$1.2M | -$272.0K | |||
| Income Tax Expense Continuing Operations | $1.1M | -$21.5M | $327.0K | $582.0K | $224.0K | |||
| Comprehensive Income Attributable To Owners Of Parent | -$152.6M | -$230.7M | -$246.4M | -$117.7M | -$123.4M | |||
| Comprehensive Income | -$152.6M | -$230.7M | -$246.4M | -$117.7M | -$123.4M | |||
| Other Nonoperating Income Expense | $22.7M | $12.5M | $6.4M | $52.8M | ||||
| Cost Of Sales | $4.6M | $1.4M | $0.00 | $0.00 | ||||
| Revenue From Contracts With Customers | $209.9M | $33.9M | $0.00 | $2.3M | $1.1M | |||
| Profit Loss Attributable To Owners Of Parent | -$155.8M | -$230.0M | -$246.3M | -$116.5M | -$123.1M | |||
| Interest Expense On Lease Liabilities | $191.0K | $225.0K | $105.0K | $141.0K | $0.00 | |||
| Income Taxes Paid Refund Classified As Operating Activities | $13.5M | $671.0K | $29.0K | $290.0K | $185.0K | |||
| Adjustments For Income Tax Expense | $1.8M | $4.6M | $327.0K | $582.0K | $224.0K | |||
| Selling And Marketing Expense | $43.4M | $44.0M | $57.5M | $69.1M | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $904.0K | -$1.3M | -$1.9M | $3.6M | ||||
| Other Comprehensive Income Loss Before OCI Equity Method Investment Net Of Tax Portion Attributable To Parent | $904.0K | -$1.2M | -$1.5M | $3.6M | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $871.0K | -$185.0K | $376.0K | -$539.0K | ||||
| Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | -$33.0K | $1.0M | $1.9M | -$4.1M | ||||
| Operating Income Loss | -$121.5M | -$130.7M | -$166.0M | -$123.3M | ||||
| Nonoperating Income Expense | -$20.1M | -$25.5M | -$29.4M | -$23.5M | ||||
| Income Tax Expense Benefit | $1.0M | $166.0K | $39.1M | $227.0K | ||||
| Income Loss From Equity Method Investments | $0.00 | -$1.5M | -$5.5M | -$10.1M | ||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$141.6M | -$156.1M | -$195.4M | -$146.8M | ||||
| Income Loss From Continuing Operations Before Equity Method Investments | -$142.6M | -$156.3M | -$234.5M | -$147.0M | ||||
| Cost Of Revenue | $5.8M | $5.9M | $2.5M | $3.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$41.0M | -$56.6M | -$38.6M | -$44.0M | -$36.5M | -$46.6M | -$46.7M | -$48.9M | -$59.4M |
| Revenue * | $15.8M | $18.1M | $17.4M | $18.0M | $17.0M | $17.8M | $14.3M | $19.2M | $19.0M |
| Research And Development Expense | $26.8M | $30.1M | $28.9M | $32.5M | $24.3M | $25.7M | $27.1M | $31.3M | $38.4M |
| General And Administrative Expense | $8.3M | $8.8M | $10.0M | $10.0M | $10.2M | $12.0M | $9.6M | $12.0M | $15.5M |
| Share Of Profit Loss Of Joint Ventures Accounted For Using Equity Method | |||||||||
| Sales And Marketing Expense | |||||||||
| Profit Loss From Operating Activities | |||||||||
| Profit Loss Before Tax | |||||||||
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | |||||||||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | |||||||||
| Other Comprehensive Income | |||||||||
| Income Tax Expense Continuing Operations | |||||||||
| Comprehensive Income Attributable To Owners Of Parent | |||||||||
| Comprehensive Income | |||||||||
| Other Nonoperating Income Expense | $925.0K | -$182.0K | $203.0K | $1.6M | $2.8M | -$2.6M | $860.0K | -$5.1M | $833.0K |
| Cost Of Sales | |||||||||
| Revenue From Contracts With Customers | |||||||||
| Profit Loss Attributable To Owners Of Parent | |||||||||
| Interest Expense On Lease Liabilities | |||||||||
| Income Taxes Paid Refund Classified As Operating Activities | |||||||||
| Adjustments For Income Tax Expense | |||||||||
| Selling And Marketing Expense | $10.7M | $10.1M | $10.6M | $10.7M | $10.7M | $11.4M | $13.7M | $14.5M | $15.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$314.0K | $704.0K | $329.0K | $541.0K | -$137.0K | -$108.0K | -$256.0K | -$314.0K | -$154.0K |
| Other Comprehensive Income Loss Before OCI Equity Method Investment Net Of Tax Portion Attributable To Parent | -$314.0K | $704.0K | $329.0K | $541.0K | -$64.0K | -$78.0K | -$332.0K | $130.0K | $102.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$267.0K | $750.0K | $371.0K | $585.0K | $17.0K | -$78.0K | -$293.0K | $170.0K | $141.0K |
| Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | $47.0K | $46.0K | $42.0K | $44.0K | $81.0K | $0.00 | $39.0K | $40.0K | $39.0K |
| Operating Income Loss | -$31.0M | -$44.1M | -$28.5M | -$35.6M | -$29.0M | -$33.6M | -$36.1M | -$39.6M | -$50.2M |
| Nonoperating Income Expense | -$10.0M | -$11.2M | -$10.0M | -$8.1M | -$6.7M | -$12.1M | -$9.3M | -$13.0M | -$7.3M |
| Income Tax Expense Benefit | $0.00 | $1.3M | $165.0K | $90.0K | $234.0K | $163.0K | -$85.0K | -$4.5M | $518.0K |
| Income Loss From Equity Method Investments | $0.00 | $0.00 | $0.00 | -$260.0K | -$597.0K | -$687.0K | -$1.4M | -$767.0K | -$1.4M |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$41.0M | -$55.4M | -$38.4M | -$43.6M | -$35.7M | -$45.8M | -$45.4M | -$52.7M | -$57.5M |
| Income Loss From Continuing Operations Before Equity Method Investments | -$41.0M | -$56.6M | -$38.6M | -$43.7M | -$35.9M | -$45.9M | -$45.3M | -$48.2M | -$58.0M |
| Cost Of Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Equity | -$185.8M | -$202.6M | -$148.2M | $79.5M | $154.0M | ||||
| Cash And Cash Equivalents | $326.4M | $466.5M | $439.2M | $115.6M | $138.8M | $262.8M | |||
| Liabilities | $509.0M | $524.6M | $503.0M | $411.4M | $451.9M | $178.2M | $26.5M | ||
| Assets | $323.2M | $322.0M | $354.8M | $490.9M | $618.0M | $513.7M | $137.7M | ||
| Stockholders Equity | -$185.8M | -$202.6M | -$148.2M | $79.5M | $154.0M | ||||
| Noncurrent Lease Liabilities | $6.6M | $7.0M | $2.5M | $4.5M | $4.5M | ||||
| Current Lease Liabilities | $1.1M | $1.0M | $1.0M | $924.0K | $924.0K | ||||
| Rightofuse Assets | $6.7M | $7.2M | $3.1M | $4.9M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $261.3M | $250.9M | $278.6M | $326.4M | $466.5M | ||||
| Intangible Assets Other Than Goodwill | $14.4M | $13.6M | $10.2M | $8.4M | |||||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $577.0K | $3.4M | $801.0K | $358.0K | $944.0K | ||||
| Purchase Of Intangible Assets Classified As Investing Activities | $1.7M | $2.9M | $2.0M | $1.8M | $1.5M | ||||
| Cash Flows From Used In Operations Before Changes In Working Capital | -$71.1M | -$211.8M | -$180.7M | -$114.7M | -$123.4M | ||||
| Cash Flows From Used In Operations | -$104.1M | -$227.5M | -$168.0M | -$122.4M | -$122.2M | ||||
| Cash Flows From Used In Operating Activities | -$136.8M | -$233.4M | -$168.7M | -$121.6M | -$121.4M | ||||
| Cash Flows From Used In Investing Activities | -$2.5M | -$6.7M | -$2.8M | -$2.2M | -$2.5M | ||||
| Cash Flows From Used In Financing Activities | -$593.0K | $267.4M | $495.0M | $100.5M | -$24.0K | ||||
| Adjustments For Increase Decrease In Trade And Other Payables | $310.0K | $6.8M | $1.9M | -$3.4M | -$858.0K | ||||
| Adjustments For Increase Decrease In Other Liabilities | $20.1M | $12.5M | $14.9M | $1.7M | $3.3M | ||||
| Adjustments For Increase Decrease In Non Current Net Defined Benefit Liability | $108.0K | -$365.0K | $276.0K | -$53.0K | $119.0K | ||||
| Adjustments For Depreciation Expense Property Plant And Equipment | $1.0M | $920.0K | $774.0K | $552.0K | $488.0K | ||||
| Adjustments For Depreciation Expense Of Right Of Use Assets | $1.2M | $1.6M | $1.2M | $1.1M | $0.00 | ||||
| Adjustments For Decrease Increase In Trade Account Receivable | -$42.8M | -$30.2M | $0.00 | $192.0K | $895.0K | ||||
| Oci Equity Method Investment After Tax Parent | $0.00 | -$103.0K | -$438.0K | $0.00 | |||||
| Inventory Write Down | $2.3M | $1.5M | $1.6M | $2.2M | |||||
| Deferred Royalty Obligation Cumulative Catch Up Adjustment | $22.2M | $11.2M | $5.0M | -$15.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Equity | -$238.2M | -$199.2M | -$238.2M | -$171.9M | -$131.7M | -$194.4M | -$64.2M | -$19.7M | $28.4M |
| Cash And Cash Equivalents | |||||||||
| Liabilities | $527.9M | $520.7M | $510.8M | $521.0M | $503.4M | $502.4M | |||
| Assets | $289.8M | $321.6M | $272.5M | $349.1M | $371.8M | $308.0M | |||
| Stockholders Equity | -$238.2M | -$199.2M | -$238.2M | -$171.9M | -$131.7M | -$194.4M | -$64.2M | -$19.7M | $28.4M |
| Noncurrent Lease Liabilities | |||||||||
| Current Lease Liabilities | |||||||||
| Rightofuse Assets | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $234.7M | $264.6M | $194.7M | $274.3M | $300.1M | $234.3M | $310.4M | $347.5M | $310.5M |
| Intangible Assets Other Than Goodwill | |||||||||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | |||||||||
| Purchase Of Intangible Assets Classified As Investing Activities | |||||||||
| Cash Flows From Used In Operations Before Changes In Working Capital | |||||||||
| Cash Flows From Used In Operations | |||||||||
| Cash Flows From Used In Operating Activities | |||||||||
| Cash Flows From Used In Investing Activities | |||||||||
| Cash Flows From Used In Financing Activities | |||||||||
| Adjustments For Increase Decrease In Trade And Other Payables | |||||||||
| Adjustments For Increase Decrease In Other Liabilities | |||||||||
| Adjustments For Increase Decrease In Non Current Net Defined Benefit Liability | |||||||||
| Adjustments For Depreciation Expense Property Plant And Equipment | |||||||||
| Adjustments For Depreciation Expense Of Right Of Use Assets | |||||||||
| Adjustments For Decrease Increase In Trade Account Receivable | |||||||||
| Oci Equity Method Investment After Tax Parent | $0.00 | $0.00 | $0.00 | $0.00 | -$73.0K | -$30.0K | $76.0K | -$444.0K | -$256.0K |
| Inventory Write Down | $237.0K | $390.0K | $1.2M | $0.00 | $288.0K | $748.0K | $0.00 | $727.0K | $53.0K |
| Deferred Royalty Obligation Cumulative Catch Up Adjustment | -$321.0K | -$184.0K | -$12.0K | -$206.0K | -$263.0K | -$263.0K | -$437.0K | $5.4M | -$129.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $1.0M | $977.0K | $1.1M | $1.0M | $0.00 | |||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$139.9M | $27.3M | $323.4M | -$23.3M | -$123.9M | |||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$208.0K | $6.0K | $235.0K | $61.0K | -$53.0K | |||
| Net Cash Provided By Used In Operating Activities | -$141.2M | -$123.8M | -$118.7M | -$138.3M | ||||
| Net Cash Provided By Used In Investing Activities | $395.0K | -$867.0K | -$3.2M | -$687.0K | ||||
| Net Cash Provided By Used In Financing Activities | $150.9M | $97.1M | $73.9M | -$897.0K | ||||
| Share Based Compensation | $6.9M | $6.6M | $13.5M | $49.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | |||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | |||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | |||
| Net Cash Provided By Used In Operating Activities | -$56.3M | -$44.1M | -$15.4M |
| Net Cash Provided By Used In Investing Activities | -$264.0K | -$531.0K | -$1.0M |
| Net Cash Provided By Used In Financing Activities | $271.0K | $356.0K | $425.0K |
| Share Based Compensation | $2.4M | $158.0K | $8.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 127.1M | 97.2M | 81.7M | 78.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 127.1M | 97.2M | 81.7M | 78.2M |
| Earnings Per Share Diluted | $-1.12 | $-1.62 | $-2.94 | $-2.01 |
| Earnings Per Share Basic | $-1.12 | $-1.62 | $-2.94 | $-2.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 136.4M | 113.7M | 107.2M | 104.8M | 95.7M | 82.6M | 82.3M | 81.5M | 80.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 136.4M | 113.7M | 107.2M | 104.8M | 95.7M | 82.6M | 82.3M | 81.5M | 80.8M |
| Earnings Per Share Diluted | $-0.30 | $-0.50 | $-0.36 | $-0.42 | $-0.38 | $-0.56 | $-0.57 | $-0.60 | $-0.73 |
| Earnings Per Share Basic | $-0.30 | $-0.50 | $-0.36 | $-0.42 | $-0.38 | $-0.56 | $-0.57 | $-0.60 | $-0.73 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Expense | $333.5M | $295.6M | $219.3M | $121.7M | $127.1M | |||
| Increase Decrease Through Transactions With Owners | $75.3M | $61.3M | $470.8M | $102.6M | $445.0K | |||
| Increase Decrease Through Sharebased Payment Transactions | $49.3M | $60.5M | $37.6M | $1.1M | $469.0K | |||
| Finance Income | $18.0M | $66.0K | $832.0K | $2.3M | $2.9M | |||
| Finance Costs | $36.9M | $18.3M | $4.9M | $156.0K | $0.00 | |||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $65.0K | $0.00 | $593.0K | $220.0K | $0.00 | $0.00 | |
| Other Non Operating Income Expense | $22.7M | $12.5M | $6.4M | $52.8M | ||||
| Interest Received Classified As Operating Activities | $1.9M | $56.0K | $797.0K | $1.2M | $1.1M | |||
| Interest Paid Classified As Operating Activities | $10.4M | $5.3M | $1.6M | $157.0K | $0.00 | |||
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$107.0K | -$185.0K | $476.0K | $128.0K | -$29.0K | |||
| Adjustments For Sharebased Payments | $49.3M | $60.5M | $37.6M | $1.1M | $469.0K | |||
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | $25.7M | $34.9M | -$45.4M | $0.00 | $0.00 | |||
| Investment Income Interest | $8.8M | $12.3M | $10.5M | $2.6M | ||||
| Depreciation | $705.0K | $1.3M | $1.2M | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Expense | |||||||||
| Increase Decrease Through Transactions With Owners | |||||||||
| Increase Decrease Through Sharebased Payment Transactions | |||||||||
| Finance Income | |||||||||
| Finance Costs | |||||||||
| Capital Expenditures Incurred But Not Yet Paid | $9.0K | $411.0K | |||||||
| Other Non Operating Income Expense | $925.0K | -$182.0K | $203.0K | $1.6M | $2.8M | -$2.6M | $860.0K | -$5.1M | $833.0K |
| Interest Received Classified As Operating Activities | |||||||||
| Interest Paid Classified As Operating Activities | |||||||||
| Adjustments For Unrealised Foreign Exchange Losses Gains | |||||||||
| Adjustments For Sharebased Payments | |||||||||
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | |||||||||
| Investment Income Interest | $2.5M | $1.9M | $2.1M | $3.4M | $3.3M | $2.9M | $2.7M | $2.4M | $2.2M |
| Depreciation | $0.00 | $362.0K | $342.0K | $336.0K | $326.0K | $331.0K | $316.0K | $273.0K | $263.0K |
Most recent annual filing with the SEC: March 10, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.